Velazquez and collaborators reported central insulin dysregulation and energy dyshomeostasis in two transgenic mouse models of AD, the Tg2576 and the triple transgenic AD (3xTg-AD) mice [194]. This evidence concerns the gene INS and Alzheimer disease.